Dual GIP/GLP-1 Receptor Agonist
Mounjaro Lawsuits
What is Mounjaro?
Mounjaro (tirzepatide) is a once-weekly injectable prescription medication manufactured by Eli Lilly and Company. Approved by the FDA in 2022 for the treatment of type 2 diabetes, Mounjaro is the first in a new class of drugs called dual GIP/GLP-1 receptor agonists. It works by activating both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
How Mounjaro Works
Mounjaro's dual-action mechanism stimulates insulin production, reduces glucagon secretion, and slows gastric emptying — more aggressively than single-action GLP-1 agonists. This enhanced effect on gastric emptying may contribute to a higher risk of gastrointestinal injuries.
Severe Injuries Associated with Mounjaro
Patients taking Mounjaro have reported serious adverse events:
- Pancreatitis: Acute inflammation of the pancreas that can be life-threatening and may cause permanent damage.
- Thyroid Tumors: Including medullary thyroid carcinoma, a rare but serious cancer.
- Gastroparesis: Stomach paralysis causing severe nausea, vomiting, and inability to digest food properly.
- Gallbladder Disease: Gallstones and inflammation that may require surgical removal.
- Kidney Failure: Acute kidney injury, sometimes requiring dialysis.
Legal Claims Against Eli Lilly
Lawsuits have been filed against Eli Lilly alleging that the company failed to adequately warn patients and healthcare providers about the risks of pancreatitis, thyroid tumors, and other severe side effects associated with Mounjaro. As the medication is relatively new, litigation is in early stages but is expected to grow significantly.
Known Side Effects
Pancreatitis, Thyroid Tumors, Gastroparesis, Gallbladder Disease, Kidney Failure, Severe Gastrointestinal Issues
FDA Warnings
The FDA requires Mounjaro to carry a boxed warning regarding the risk of thyroid C-cell tumors. Additional warnings cover pancreatitis, gallbladder disease, kidney failure, hypoglycemia, and gastrointestinal disorders. The FDA continues to monitor adverse event reports.
Legal Status
Mounjaro lawsuits are being filed against Eli Lilly alleging failure to warn about pancreatitis, thyroid tumors, and other severe side effects. Litigation is in early stages but expected to grow as more patients report injuries.
Were you injured by Mounjaro?
Get a free, confidential case review. No fee unless you win.
Free Mounjaro Case Review